Onasemnogene abeparvovec in spinal muscular atrophy: an Australian experience of safety and efficacy.
D'Silva AM, Holland S, Kariyawasam D, Herbert K, Barclay P, Cairns A, MacLennan SC, Ryan MM, Sampaio H, Smith N, Woodcock IR, Yiu EM, Alexander IE, Farrar MA.
D'Silva AM, et al.
Ann Clin Transl Neurol. 2022 Mar;9(3):339-350. doi: 10.1002/acn3.51519. Epub 2022 Feb 16.
Ann Clin Transl Neurol. 2022.
PMID: 35170254
Free PMC article.